Table 4. Polycondensed benzothiophene derivatives from Pfizer.
| ||||
---|---|---|---|---|
Compd | R1 | R2 | IC50a (nM) | EC50b (nM) |
20 | H | H | 180 | 1400 |
21 | Me | H | 40 | 700 |
22 | H | Me | 300 | 3800 |
23 | CH2OH | H | 14 | 400 |
24 | CH2NH | H | 5 | 2600 |
25 | 16 | 90 | ||
26 | H | 1 | 50 | |
27 | Cl | 2 | 130 | |
28 | Ph | 9 | 180 | |
29 | 5 | 220 | ||
30, PF022 | 5 | 150 | ||
31, PF318 | 25 | 255 | ||
32, PF029 | 2 | 150 |
Expressed as the inhibition of MK2 ability to phosphorylate the KKKALSRQLSVAA peptide.
Expressed as the ability to inhibit TNFα production in LPS-stimulated U937 cells.